ZNF331 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.36900515765615E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.3246995701528E-10 |
Normal-vs-Stage2 |
4.9126000000177E-06 |
Normal-vs-Stage3 |
2.0495827257605E-12 |
Normal-vs-Stage4 |
3.23630011678233E-13 |
Stage1-vs-Stage2 |
3.818800E-01 |
Stage1-vs-Stage3 |
1.283670E-02 |
Stage1-vs-Stage4 |
6.621300E-04 |
Stage2-vs-Stage3 |
4.939900E-02 |
Stage2-vs-Stage4 |
1.734450E-02 |
Stage3-vs-Stage4 |
2.291800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.70600200632975E-11 |
Normal-vs-AfricanAmerican |
2.115800E-03 |
Normal-vs-Asian |
5.78170000764544E-09 |
Caucasian-vs-AfricanAmerican |
2.404000E-01 |
Caucasian-vs-Asian |
5.614200E-01 |
AfricanAmerican-vs-Asian |
1.294580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.60249599648432E-11 |
Normal-vs-Female |
5.06960029511561E-10 |
Male-vs-Female |
5.586200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.4722892883774E-13 |
Normal-vs-Age(41-60Yrs) |
1.32740041181023E-10 |
Normal-vs-Age(61-80Yrs) |
7.69869723526995E-11 |
Normal-vs-Age(81-100Yrs) |
8.28920265760758E-11 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.577300E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.766400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.033600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.310000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.722400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.034400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.25239999984694E-08 |
Normal-vs-Grade 2 |
1.03590003242005E-09 |
Normal-vs-Grade 3 |
3.53650442264097E-12 |
Normal-vs-Grade 4 |
3.0009328355618E-13 |
Grade 1-vs-Grade 2 |
9.511800E-01 |
Grade 1-vs-Grade 3 |
4.514100E-02 |
Grade 1-vs-Grade 4 |
1.789750E-02 |
Grade 2-vs-Grade 3 |
3.826400E-04 |
Grade 2-vs-Grade 4 |
5.91829999999627E-05 |
Grade 3-vs-Grade 4 |
1.222760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.4488967237678E-11 |
Normal-vs-ccB subtype |
7.00560054411881E-10 |
ccA subtype-vs-ccB subtype |
3.851000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.21189766292218E-11 |
Normal-vs-N1 |
1.68298708302927E-12 |
N0-vs-N1 |
5.980200E-04 |
|
|